Clinical Trial Update: Safety of and Immune Response to Polyvalent HIV-1 Vaccine in HIV Uninfected Adults [Phase 1]

View source ↗

Summary

Phase 1 trial update of a polyvalent HIV-1 vaccine in HIV-uninfected adults focusing on safety and immune response.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Polyvalent HIV-1 vaccine (polyvalent HIV-1 vaccine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 1 | Status: UNKNOWN